Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study

NCT02134028 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02134028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02134028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
August 5, 2014
Completion date
October 11, 2019
Enrollment
2,282 (actual)
Sites
365

Conditions

As the registry lists them; a condition with its own page is linked.

asthma